Patents by Inventor Marie-Josee Hebert

Marie-Josee Hebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-LG3 antibodies and uses thereof
    Patent number: 8795974
    Abstract: A method for the prediction of the risk and/or the diagnosis of vascular damage such as acute vascular rejection in a subject, based on the determination of anti-LG3 antibodies levels in a sample from the subject, is disclosed.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: August 5, 2014
    Assignee: Val-Chum, Limited Partnership
    Inventors: Marie-Josee Hebert, Heloise Cardinal, Nathalie Brassard
  • ANTI-LG3 ANTIBODIES AND USES THEREOF
    Publication number: 20130004978
    Abstract: A method for the prediction of the risk and/or the diagnosis of vascular damage such as acute vascular rejection in a subject, based on the determination of anti-LG3 antibodies levels in a sample from the subject, is disclosed.
    Type: Application
    Filed: March 8, 2011
    Publication date: January 3, 2013
    Inventors: Marie-Josee Hebert, Heloise Cardinal, Nathalie Brassard
  • SOLUBLE FAS IN ACUTE CORONARY SYNDROMES DIAGNOSIS
    Publication number: 20110014638
    Abstract: The present technology provides methods and materials for the early clinical detection of acute coronary syndromes in a subject. The methods and materials comprise measuring the amount of soluble Fas in a sample obtained from a subject, comparing the amount of soluble sFas with a reference value and detecting the presence of acute coronary syndromes.
    Type: Application
    Filed: October 31, 2008
    Publication date: January 20, 2011
    Applicants: Hopital Du Sacre-Coeur De Montreal, Centre Hospitalier De L'Universite De Montreal
    Inventors: François Madore, Marie-Josée Hebert, Héloise Cardinal, Peter Bogaty, James Brophy